WHO ICTRP trial
Neoadjuvant Therapy's Impact on the Immune Microenvironment in Prostate Cancer
ChiCTR2400092934 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR2400092934 |
|---|---|
| Public title | Neoadjuvant Therapy's Impact on the Immune Microenvironment in Prostate Cancer |
| Scientific title | Neoadjuvant Therapy's Impact on the Immune Microenvironment in Prostate Cancer |
| Primary sponsor | West China hospital, Sichuan University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Observational study |
| Phase | Retrospective study |
| Countries | China |
| Conditions | prostate cancer |
| Interventions | prostate cancer patient with neoadjuvant hormonal therapy:none;prostate cancer patient without neoadjuvant hormonal therapy:none |
| Registration date | Nov 26, 2024 |
| Target size | prostate cancer patient with neoadjuvant hormonal therapy:32;prostate cancer… |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: